PetCaseFinder

Peer-reviewed veterinary case report

Histological and Immunohistochemical Evaluation of Phosphorylated Mechanistic Target of Rapamycin in Canine Skin Tumours.

Journal:
Journal of comparative pathology
Year:
2021
Authors:
Mathew, Raimon et al.
Affiliation:
Department of Veterinary Pathology · India
Species:
dog

Abstract

The mechanistic target of rapamycin (mTOR) plays an important role in cellular functions, including growth and metabolism. Recently, mTOR and the activated phosphorylated form of mTOR (p-mTOR) have been reported as potential prognostic markers in many human tumours. However, there are few studies on its activation in canine tumours. We investigated the expression of p-mTOR in 17 canine skin tumours (CSTs), of which 58.8% were epithelial and melanocytic and 41.2% were mesenchymal tumours. Seventy-six per cent of the CSTs had high or moderate expression of p-mTOR. Mean p-mTOR expression in the epithelial and melanocytic tumours (5.7&#xa0;&#xb1;&#xa0;0.56) was significantly higher (P&#xa0;<0.05) than that of the mesenchymal tumours (3.14&#xa0;&#xb1;&#xa0;0.55). The age of the animals had no influence on p-mTOR expression. These findings suggest that activation of m-TOR is important in the development of skin tumours in dogs and the study might form the basis for further research on utilizing m-TOR inhibitors as improved therapeutic modalities in canine skin tumours.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/33894879/